IL43474A - Process for the manufacture of insulin and of analogs and derivatives thereof - Google Patents

Process for the manufacture of insulin and of analogs and derivatives thereof

Info

Publication number
IL43474A
IL43474A IL43474A IL4347473A IL43474A IL 43474 A IL43474 A IL 43474A IL 43474 A IL43474 A IL 43474A IL 4347473 A IL4347473 A IL 4347473A IL 43474 A IL43474 A IL 43474A
Authority
IL
Israel
Prior art keywords
insulin
analogs
derivatives
manufacture
Prior art date
Application number
IL43474A
Other languages
English (en)
Other versions
IL43474A0 (en
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL43474A0 publication Critical patent/IL43474A0/xx
Publication of IL43474A publication Critical patent/IL43474A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
IL43474A 1972-10-25 1973-10-24 Process for the manufacture of insulin and of analogs and derivatives thereof IL43474A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19722252157 DE2252157C3 (de) 1972-10-25 1972-10-25 Zwischenprodukte zur herstellung von insulin, insulin-analogen und -derivaten und verfahren zur herstellung von insulin, insulin analogen und derivaten

Publications (2)

Publication Number Publication Date
IL43474A0 IL43474A0 (en) 1974-01-14
IL43474A true IL43474A (en) 1978-01-31

Family

ID=5859936

Family Applications (1)

Application Number Title Priority Date Filing Date
IL43474A IL43474A (en) 1972-10-25 1973-10-24 Process for the manufacture of insulin and of analogs and derivatives thereof

Country Status (15)

Country Link
US (1) US3883496A (sv)
JP (1) JPS528835B2 (sv)
AT (1) AT329780B (sv)
AU (1) AU6171773A (sv)
BE (1) BE806522A (sv)
CA (1) CA1011734A (sv)
CH (1) CH602597A5 (sv)
DD (1) DD109214A5 (sv)
DE (1) DE2252157C3 (sv)
FR (1) FR2204616B1 (sv)
GB (1) GB1453454A (sv)
HU (1) HU173215B (sv)
IL (1) IL43474A (sv)
NL (1) NL7314433A (sv)
SE (1) SE7314471L (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2428412A1 (de) * 1974-06-12 1976-01-15 Hoechst Ag Verfahren zur herstellung von insulin, insulin-analogen und -derivaten
USRE32015E (en) * 1974-06-12 1985-10-29 Hoechst Aktiengesellschaft Process for the manufacture of insulin, analogs and derivatives thereof
DE2439296A1 (de) * 1974-08-16 1976-02-26 Hoechst Ag Verfahren zur herstellung von insulin, insulin-analogen und -derivaten
US5008241A (en) * 1985-03-12 1991-04-16 Novo Nordisk A/S Novel insulin peptides
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
US4659006A (en) * 1985-09-26 1987-04-21 Rca Corporation Method of bonding a die to a substrate
DE10075034I1 (de) * 1987-02-25 2001-05-23 Novo Nordisk As Insulinderivate
US4992418A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin
US4992417A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogues
EP0428849A3 (en) * 1989-09-28 1991-07-31 Hoechst Aktiengesellschaft Retroviral protease inhibitors
US5646242A (en) 1994-11-17 1997-07-08 Eli Lilly And Company Selective acylation of epsilon-amino groups
US5700904A (en) * 1995-06-07 1997-12-23 Eli Lilly And Company Preparation of an acylated protein powder
US5631347A (en) * 1995-06-07 1997-05-20 Eli Lilly And Company Reducing gelation of a fatty acid-acylated protein
WO2011031662A1 (en) 2009-09-08 2011-03-17 Kent Stephen B H Ester insulin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH77A (de) * 1889-01-09 Christian Herren Wurzelschneidmaschine
IE36225B1 (en) * 1971-01-28 1976-09-15 Nat Res Dev Improvements relating to insulin derivatives

Also Published As

Publication number Publication date
AU6171773A (en) 1975-04-24
FR2204616B1 (sv) 1978-10-27
SE7314471L (sv) 1974-04-26
DD109214A5 (sv) 1974-10-20
ATA901073A (de) 1975-08-15
DE2252157C3 (de) 1976-03-18
FR2204616A1 (sv) 1974-05-24
DE2252157A1 (de) 1974-05-09
AT329780B (de) 1976-05-25
DE2252157B2 (de) 1975-07-24
HU173215B (hu) 1979-03-28
CA1011734A (en) 1977-06-07
NL7314433A (sv) 1974-04-29
JPS528835B2 (sv) 1977-03-11
IL43474A0 (en) 1974-01-14
GB1453454A (en) 1976-10-20
CH602597A5 (sv) 1978-07-31
US3883496A (en) 1975-05-13
BE806522A (fr) 1974-04-25
JPS4980090A (sv) 1974-08-02

Similar Documents

Publication Publication Date Title
IL43474A (en) Process for the manufacture of insulin and of analogs and derivatives thereof
IL43735A0 (en) New derivatives of ypsilon-glutamyl-4-nitroanilide and processes for the preparation thereof
IL43495A0 (en) Process for the manufacture of insulin,analogs and derivatives thereof
CH614188A5 (en) Process for the preparation of novel aminophenylethanolamines
ZA741910B (en) Process for the manufacture of 2-arylamino-2-imidazoline derivative and their salts
AU6198173A (en) Manufacture of insulin
EG10850A (en) Process for the preparation of 1-hydroxy-pyridones
IL47443A (en) Process for the manufacture of insulin analogs and derivatives thereof
IL41614A (en) The production of insulin derivatives
GB1407649A (en) Process for the preparation of thiazole-sulphenamides
EG11434A (en) Process for the manufacture of n-benzhydryl-n-p-hydroxybenzyl-piperazines
HK62977A (en) Process for the manufacture of triacetone-amine
PH11915A (en) Process for the preparation of 2-amino-4-phenyl-imidazoline derivatives
CH614430A5 (en) Process for the preparation of substituted phenylguanidines
MY7900116A (en) Process for the production of 6-piperazinyl-morphanthridinies and related triylcics
ZA738587B (en) Process for the preparation of thiazolesulphenamides
ZA731178B (en) Process for the preparation of alpha-6-deoxytetracyclines
YU36724B (en) Process for the manufacture of benzodioxole derivatives
KR780000135B1 (en) Process for the preparation of oxazolidines
GB1405791A (en) Process for the preparation of pyridoindolobenzazepines
YU19073A (en) Process for the manufacture of cyanoalkylaminopropanes
HK55678A (en) New lactams and process for the manufacture of these compounds
GB1405218A (en) Process for the manufacture of 2-aryl-v-triazoles
IL43123A0 (en) Process for the manufacture of 7-amino-3-cephem-4-carboxylic acid derivatives
IL43137A0 (en) Derivatives of glycyrhetinic acid and processes for the preparation thereof